2024 HFSA CME Symposium - From Evidence to Practice: Treating Iron Deficiency with Intravenous Iron in Heart Failure

By: PRLog

This CME Symposium takes place on Sunday, September 29, 2024 from 5:30 - 6:30 PM ET during the 2024 Heart Failure Society of America (HFSA) Annual Scientific Meeting at the Signia by Hilton Atlanta in Atlanta, Georgia in the Triumph Ballroom G.

HAZLET, N.J. - Aug. 12, 2024 - PRLog -- In this educational initiative, to take place at the 2024 Heart Failure Society of America annual meeting, attendees will be provided with information on the detrimental impact of ID in patients with HF, tests for screening for ID, a definition to determine a diagnosis of ID, and evidence demonstrating the benefits achieved with IV iron therapy. A case study will focus on overcoming challenges in HF patient care with multidisciplinary teamwork, following best practices outlined in an expert-generated algorithm published in a scientific statement from the Heart Failure Society of America (HFSA).

The educational objectives include:

  • Recognize the deleterious consequences of iron deficiency, with or without anemia, in HF
  • Describe the importance of regular screening for iron deficiency in HF patients
  • Identify the drawbacks of, and explain evidence associated with oral iron supplementation for treating iron deficiency in HF
  • Interpret clinical evidence with intravenous iron therapy for iron deficiency in patients with HF
  • Identify potential challenges to diagnosing and treating iron deficiency in HF patients and recognize the effective contributions made by multi-disciplinary healthcare personnel in addressing these challenges

Click here for more information

CHAIR
Javed Butler, MD, MPH, MBA

President, Baylor Scott and White Research Institute
Dallas, Texas
Distinguished Professor of Medicine
University of Mississippi
Jackson, Mississippi

FACULTY
Nancy M. Albert, PhD, CCNS, CHFN, CCRN, NE-BC

Associate Chief Nursing Officer—Research and Innovation
Clinical Nurse Specialist—Kaufman Center for Heart Failure
Cleveland Clinic
Cleveland, Ohio

Stormi Gale, PharmD
Heart and Vascular Institute
Novant Health
Huntersville, North Carolina

Robert Mentz, MD
Associate Professor of Medicine
Associate Professor in Population Health Sciences
Duke University School of Medicine
Durham, North Carolina

This educational activity is intended for clinicians who manage patients with heart failure.

This activity is supported by an independent educational grant from American Regent.

Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Voxmedia LLC designates this live activity for a maximum of 1.0 AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1.0 Credits™ through its reciprocity agreements. The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Contact
Voxmedia
***@voxmedia.us

Photos: (Click photo to enlarge)

Voxmedia Logo 2024 HFSA CME Symposium


Source: CMEPlanet

Read Full Story - 2024 HFSA CME Symposium - From Evidence to Practice: Treating Iron Deficiency with Intravenous Iron in Heart Failure | More news from this source

Press release distribution by PRLog

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.